Model: | Ratio |
Symbol | Title | Sector | Industry | M.Cap.[M] | Div Yield | Last Close | AvgVol 200d |
NVO | Novo Nordisk A/S | Healthcare | Biotechnology | 586670 | 0.011 | 131.91 | 4226167 |
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 817830 | 0.0057 | 908.27 | 3016243 |
Entry Threshold: | 2.00 | Exit Threshold: | 0.00 | ||
Max Duration: | 20 | Entry Mode: | Uptick | Reversals: | |
MA Period: | 15 | MA Type: | EMA | StdDev Period: | 15 |
RSI Period: | 14 | RSI Threshold: | 0 | ||
Margin Req. 1: | 50.0 | Margin Req. 2: | 50.0 | ||
Version: | 5 | Model Version: | 2016.1 | Bid-Ask 0.01 / 0.01 |
Initial Capital: | 10000.00 | Final Equity: | 11398.86 |
Total net P/L: | 1398.86 | Total ROI: | 13.99 % |
CAGR: | 30.03 % | Max. DD: | 4.50 % |
System Score: | 20.502 | Sharpe Ratio: | 1.377 |
Start Date: | 2023-06-01 | End Date: | 2023-11-30 |
Total days: | 182 | ||
Commissions: | 32.00 | Comm.% P/L | 2.24 % |
Total Transactions: | 32 | Log. Linearity: | 88.057 % |
Total | Long | Short | NVO | LLY | |
---|---|---|---|---|---|
Total Profit/Loss | 1430.86 | 754.53 | 676.33 | 896.86 | 534.00 |
Total Profit | 1704.19 | 1027.86 | 676.33 | 2326.76 | 2030.41 |
Total Loss | 273.33 | 273.33 | 0.00 | 1429.90 | 1496.41 |
Profit Factor | 6.23 | 3.76 | 0.00 | 1.63 | 1.36 |
Trades | 8 | 5 | 3 | 8 | 8 |
Winning Trades | 6 | 3 | 3 | 4 | 4 |
Losing Trades | 2 | 2 | 0 | 4 | 4 |
% Profitable | 75.00 | 60.00 | 100.00 | 50.00 | 50.00 |
Profit/Loss Per Trade % | 1.69 | 1.40 | 2.18 | 0.92 | 0.55 |
Profit Per Trade % | 2.72 | 3.28 | 2.18 | 5.36 | 4.82 |
Loss Per Trade % | 1.35 | 1.35 | 0.00 | 3.31 | 3.47 |
Days In Trade | 83 | 62 | 21 | 83 | 83 |
Days In Trade (Avg. Per Trade) | 10.38 | 12.40 | 7.00 | 10.38 | 10.38 |
% Days In Trade | 45.60 | 34.07 | 11.54 | 45.60 | 45.60 |